A detailed history of State Of Michigan Retirement System transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Of Michigan Retirement System holds 30,638 shares of HALO stock, worth $1.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,638
Previous 32,438 5.55%
Holding current value
$1.74 Million
Previous $1.32 Million 21.61%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$37.81 - $52.4 $68,058 - $94,320
-1,800 Reduced 5.55%
30,638 $1.6 Million
Q1 2024

Apr 18, 2024

BUY
$33.68 - $41.95 $23,576 - $29,365
700 Added 2.21%
32,438 $1.32 Million
Q4 2023

Jan 22, 2024

BUY
$33.32 - $42.1 $6,664 - $8,420
200 Added 0.63%
31,738 $1.17 Million
Q3 2023

Oct 27, 2023

SELL
$36.46 - $44.03 $32,814 - $39,627
-900 Reduced 2.77%
31,538 $1.2 Million
Q2 2023

Jul 26, 2023

SELL
$30.28 - $38.74 $51,476 - $65,858
-1,700 Reduced 4.98%
32,438 $1.17 Million
Q1 2023

Apr 28, 2023

SELL
$32.86 - $55.7 $9,858 - $16,710
-300 Reduced 0.87%
34,138 $1.3 Million
Q4 2022

Jan 27, 2023

SELL
$40.06 - $59.44 $12,018 - $17,832
-300 Reduced 0.86%
34,438 $0
Q3 2022

Oct 24, 2022

SELL
$38.53 - $51.78 $11,559 - $15,534
-300 Reduced 0.86%
34,738 $1.37 Million
Q2 2022

Aug 08, 2022

SELL
$37.35 - $48.3 $26,145 - $33,810
-700 Reduced 1.96%
35,038 $1.54 Million
Q1 2022

May 04, 2022

BUY
$31.97 - $41.06 $1,214 - $1,560
38 Added 0.11%
35,738 $1.43 Million
Q3 2021

Oct 27, 2021

BUY
$38.47 - $46.42 $76,940 - $92,840
2,000 Added 5.93%
35,700 $1.45 Million
Q2 2021

Jul 27, 2021

SELL
$38.84 - $51.31 $520,456 - $687,554
-13,400 Reduced 28.45%
33,700 $1.53 Million
Q1 2021

May 03, 2021

BUY
$39.51 - $51.45 $31,608 - $41,160
800 Added 1.73%
47,100 $1.96 Million
Q4 2020

Feb 01, 2021

BUY
$25.81 - $43.62 $1.2 Million - $2.02 Million
46,300 New
46,300 $1.98 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.93B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track State Of Michigan Retirement System Portfolio

Follow State Of Michigan Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Michigan Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Of Michigan Retirement System with notifications on news.